Telsite H 80+12.5MG

Telmisartan 80 mg + Hydrochlorothiazide 12.5 mg

Treatment of hypertension (high blood pressure), especially when blood pressure is not adequately controlled with telmisartan alone; helps reduce risk of cardiovascular events associated with uncontrolled hypertension.

Telmisartan is an angiotensin II receptor blocker (ARB) that relaxes blood vessels by blocking angiotensin II, lowering blood pressure. Hydrochlorothiazide is a thiazide diuretic that increases salt and water excretion via the kidneys, reducing blood volume and blood pressure.

Oral tablet. Take as prescribed, usually once daily at the same time each day, with or without food. Swallow whole with water; do not stop abruptly without medical advice.

dizziness, headache, fatigue, low blood pressure, increased urination, dehydration, nausea, electrolyte imbalance (low potassium/low sodium), increased uric acid, increased blood sugar

Not recommended in pregnancy (can harm fetus). Use caution in kidney or liver disease, dehydration, low blood pressure, electrolyte imbalance, gout, diabetes, and in the elderly. Monitor blood pressure, kidney function (creatinine), and electrolytes (potassium, sodium). May cause dizziness—avoid driving if affected. Risk of photosensitivity with hydrochlorothiazide; use sun protection.

ACE inhibitors or aliskiren (higher risk of kidney impairment, high potassium, low BP; avoid in diabetes with aliskiren), potassium supplements/potassium-sparing diuretics (risk of hyperkalemia), NSAIDs (reduced effect and kidney risk), lithium (toxicity), other antihypertensives (additive low BP), corticosteroids/ACTH (electrolyte loss), antidiabetic medicines (dose adjustment may be needed), alcohol (increases dizziness/low BP)

Store below 25°C in a dry place, protected from light and moisture. Keep in original blister pack and out of reach of children.

Telma-H 80/12.5 Tablet, Telmikind-H 80 Tablet, Tazloc-H 80 Tablet, Cresar-H 80 Tablet, Twynsta-H (equivalent strength varies)